|
ZFYVE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.83570000498324E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40020000038987E-07 |
| Normal-vs-Stage2 |
1.195120E-03 |
| Normal-vs-Stage3 |
2.75060000332061E-08 |
| Normal-vs-Stage4 |
1.73039999995517E-07 |
| Stage1-vs-Stage2 |
5.074100E-02 |
| Stage1-vs-Stage3 |
2.908000E-01 |
| Stage1-vs-Stage4 |
3.275400E-01 |
| Stage2-vs-Stage3 |
1.173990E-02 |
| Stage2-vs-Stage4 |
2.884400E-02 |
| Stage3-vs-Stage4 |
8.524200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52989999452546E-08 |
| Normal-vs-AfricanAmerican |
6.43900000000253E-05 |
| Normal-vs-Asian |
6.1226999999997E-05 |
| Caucasian-vs-AfricanAmerican |
3.811400E-01 |
| Caucasian-vs-Asian |
9.811600E-02 |
| AfricanAmerican-vs-Asian |
7.186600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.14510000054958E-07 |
| Normal-vs-Female |
6.94449999727453E-08 |
| Male-vs-Female |
5.498000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.39040000016288E-07 |
| Normal-vs-Age(41-60Yrs) |
6.90619999965669E-07 |
| Normal-vs-Age(61-80Yrs) |
2.80999999935361E-08 |
| Normal-vs-Age(81-100Yrs) |
2.216700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.155200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.943600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.243200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.420010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.876820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.758800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.261920E-02 |
| Classical-VS-Follicular |
4.977400E-01 |
| Classical-VS-Other |
4.599000E-01 |
| Classical-VS-Normal |
2.04130000014402E-07 |
| Tall-VS-Follicular |
1.758450E-02 |
| Tall-VS-Other |
8.149200E-01 |
| Tall-VS-Normal |
2.68139999093364E-09 |
| Follicular-VS-Other |
4.458200E-01 |
| Follicular-VS-Normal |
4.78950000004641E-06 |
| Other-VS-Normal |
9.378900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.99570000034311E-07 |
| Normal-vs-N1 |
1.21900000094044E-08 |
| N0-vs-N1 |
1.197890E-02 |
|
|
